SMOORE INTL (06969) announced its interim results, with adjusted profit approximately 757 million yuan, an increase of 2.6% year-on-year.

SMOORE INTL (06969) announced its mid-term results for 2026, with revenue of approximately HK$7.209 billion, a year-on-year increase of 19.9%; gross profit of approximately HK$2.322 billion, a year-on-year increase of 3.5%; profit for the period of approximately HK$572 million, a year-on-year increase of 16.2%; and adjusted profit for the period of approximately HK$757 million, a year-on-year increase of 2.6%. The announcement stated that the revenue growth was primarily driven by the group's ToB business, particularly the continued expansion of its electronic vaporization and HNB businesses. During the review period, the ToB business contributed approximately HK$5.91 billion in revenue, representing a year-on-year increase of about 24.7%. The ToB business mainly includes sales of electronic vaporization products, HNB products, specialized vaporization products, and the provision of related technical services around vaporization medicine. During the review period, these businesses each achieved year-on-year revenue growth. The increase in profit for the period is mainly attributed to: (i) the increase in revenue from the enterprise customer-focused business during the review period, primarily driven by revenue from heated non-combustible products and electronic vaporization products; and (ii) a decrease in the groups share-based payment expenses during the review period compared to the same period last year, as several share-based payment expense recognition periods gradually expired.